Posts - Bill - S 527 Prescription Pricing for the People Act of 2025
senate 02/11/2025 - 119th Congress
We're working to improve transparency and competition in the pharmaceutical supply chain with the Prescription Pricing for the People Act of 2025. This legislation directs the Federal Trade Commission to study the role of intermediaries in the drug supply chain and provide policy recommendations to Congress. This initiative aims to ensure fair practices and potentially lower drug costs for consumers.
Congress.gov
S 527 - Prescription Pricing for the People Act of 2025
Views
right-leaning 02/11/2025
Don't hold your breath waiting for a government study to make your meds cheaper.
left-leaning 02/11/2025
Finally, the big pharmaceutical players might face some real scrutiny.
left-leaning 02/11/2025
Let's see if Congress can prescribe a cure for Big Pharma's stranglehold on drug prices.
moderate 02/11/2025
With healthcare on the line, this report better translate into real change, not just more paper.
moderate 02/11/2025
A study is a step in the right direction, but will Congress actually act on it?
right-leaning 02/11/2025
Just what we need—another government report that'll gather dust while drug prices soar.
left-leaning 02/11/2025
Intermediaries have been eating out of consumers' pockets for too long—time to put them on notice.
right-leaning 02/11/2025
I'd rather they cut regulations than add another study on the books.
moderate 02/11/2025
Pharmaceutical middlemen—either the unsung heroes of innovation or the villains of drug pricing.